Aleksandr S Lipatov

Title: Innovations of Aleksandr S Lipatov

Introduction

Aleksandr S Lipatov is a prominent inventor based in Atlanta, GA (US). He has made significant contributions to the field of virology, particularly in the development of improved influenza vaccines. With a total of 4 patents to his name, Lipatov's work is recognized for its potential impact on public health.

Latest Patents

One of his latest patents focuses on a modified influenza virus for monitoring and improving vaccine efficiency. The immunogenicity of the influenza virus hemagglutinin (HA) molecule can be enhanced by substituting specific amino acids in the HA sequence. For instance, the substitution of asparagine at position 223 of H5 HA increases the sensitivity of the hemagglutinin inhibition (HI) assay by altering receptor specificity and/or antibody-antigen binding. These HA molecules containing such substitutions are expected to be useful in the development of diagnostic reference viruses and improved influenza vaccines.

Career Highlights

Lipatov is currently affiliated with St. Jude Children's Research Hospital, where he continues to advance his research in influenza virus modifications. His work is crucial in the ongoing efforts to enhance vaccine efficacy and public health safety.

Collaborations

He has collaborated with notable colleagues in the field, including Erich Hoffmann and Richard John Webby. Their combined expertise contributes to the innovative research being conducted at St. Jude Children's Research Hospital.

Conclusion

Aleksandr S Lipatov's contributions to the field of virology and vaccine development are noteworthy. His innovative approaches to enhancing influenza vaccine efficiency demonstrate his commitment to improving public health outcomes.